|SECURITIES AND EXCHANGE
COMMISSION
|----------------------------------



|WASHINGTON, DC 20549
|--------------------

|
|



|FORM 8-K
|--------



|CURRENT REPORT  PURSUANT TO
SECTION 13 OR 15(d) OF THE  SECURITIES EXCHANGE ACT OF 1934
|---------------------------------------------------------------------------------------



|April 24, 2003
|--------------



|Date of Report  (Date of
earliest event reported)
|-------------------------------------------------



|HUMAN GENOME SCIENCES, INC.
|---------------------------



|(Exact Name of Registrant as
Specified in Charter)
|--------------------------------------------------

|                                      |  |                         
|------------------------------------- |  | ------------------------
|Delaware                              |  | 0-022962                
|(State or Other Jurisdiction
      of |  | (Commission File Number)
|Incorporation)                        | 



|9410 Key West Avenue, Rockville, Maryland
                       20850-3338
      
      (Address of Principal Executive Offices)                      
          (ZIP Code)
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|Registrant's telephone number,
including area code: (301) 309-8504
|------------------------------------------------------------------



|(Former Name or Former Address, if
Changed Since Last Report)
|-------------------------------------------------------------



| |  | 
| |  | 



---





|Item 9. | Regulation FD Disclosure (Item 12, Disclosure of Results of Operations and Financial
Condition).
|------- | ------------------------------------------------------------------------------------------------





|The following
information is furnished pursuant to Item 12, "Disclosure of Results of Operations
and Financial  Condition":
|---------------------------------------------------------------------------------------------------------------------------



|On April 24, 2003,
Human Genome Sciences, Inc. issued a press release reporting its financial results for
the three  months ended March 31, 2003.  The press release is attached hereto as Exhibit
99.1.
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|Item 7. | Financial Statements and Exhibits.
|------- | ----------------------------------



|(c)  Exhibits
|-------------

|Exhibit |  | Description                               | 
|------- |  | ----------------------------------------- | 
|99.1    |  | Press Release issued April 24,
      2003 | 



|SIGNATURES
|----------



|Pursuant to the
requirements of the Securities  Exchange Act of 1934, the Registrant has duly caused this
report to be signed  on its behalf by the undersigned hereunto duly authorized.
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|                     | HUMAN GENOME SCIENCES, INC.
|-------------------- | ---------------------------
|                     |                            
|Date: April 24, 2003 | By:                        



| |  | 
| |  | 



---